(Q46797459)

25 December 2017

title

Pomegranate juice supplementation in chronic obstructive pulmonary disease: a 5-week randomized, double-blind, placebo-controlled trial (English)

1 reference

25 December 2017

chronic obstructive pulmonary disease

main subject

1 reference

1 reference

Francisco A Tomas-Barberan

6

1 reference

25 December 2017

Juan Carlos Espín

7

1 reference

25 December 2017

author name string

Cerdá B

1

1 reference

25 December 2017

Soto C

2

1 reference

25 December 2017

Albaladejo MD

3

1 reference

25 December 2017

Martínez P

4

1 reference

25 December 2017

Sánchez-Gascón F

5

1 reference

25 December 2017

publication date

1 February 2006

1 reference

25 December 2017

European Journal of Clinical Nutrition

published in

1 reference

25 December 2017

volume

60

1 reference

25 December 2017

issue

2

1 reference

25 December 2017

page(s)

245-253

1 reference

25 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.ejcn.1602309

exact match

0 references

cites work

Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602309

Prospects for new drugs for chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602309

The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy-6H-dibenzopyran-6-one derivatives by the colonic microflora of healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602309

Evaluation of the bioavailability and metabolism in the rat of punicalagin, an antioxidant polyphenol from pomegranate juice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602309

Metabolism of antioxidant and chemopreventive ellagitannins from strawberries, raspberries, walnuts, and oak-aged wine in humans: identification of biomarkers and individual variability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602309

Inhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602309

Flavonoid-rich dark chocolate improves endothelial function and increases plasma epicatechin concentrations in healthy adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602309

Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602309

Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602309

ROS in the local and systemic pathogenesis of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602309

Phyto-oestrogens and breast cancer chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602309

Oxidants/antioxidants and COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602309

Outline of the beginnings of alchemy and its antecedents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602309

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602309

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602309

Antioxidant activities of pomegranate fruit extract and its anthocyanidins: delphinidin, cyanidin, and pelargonidin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602309

Urine 8-isoprostane F2alpha concentrations in patients with neurogenic bladder due to spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602309

Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602309

F(2)-isoprostanes: sensitive and specific non-invasive indices of lipid peroxidation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602309

Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602309

Oxidative Stress in Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602309

Lipid peroxidation and 5-lipoxygenase activity in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602309

Studies on the antioxidant activity of pomegranate (Punica granatum) peel and seed extracts using in vitro models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602309

Chronic obstructive pulmonary disease and intake of catechins, flavonols, and flavones: the MORGEN Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602309

Endotoxin exposure as a major determinant of lung function decline in pig farmers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602309

Flavanol-rich cocoa drink lowers plasma F(2)-isoprostane concentrations in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602309

Inhibition of carcinogenesis by dietary polyphenolic compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602309

Systemic oxidative stress in asthma, COPD, and smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602309

Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602309

7 January 2021

Pomegranate juice supplementation to atherosclerotic mice reduces macrophage lipid peroxidation, cellular cholesterol accumulation and development of atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602309

7 January 2021

Consumption of flavonoids in onions and black tea: lack of effect on F2-isoprostanes and autoantibodies to oxidized LDL in healthy humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602309

7 January 2021

Exposure to biomass smoke and chronic airway disease in Mexican women. A case-control study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602309

7 January 2021

Measurement of urinary F(2)-isoprostanes as markers of in vivo lipid peroxidation-A comparison of enzyme immunoassay with gas chromatography/mass spectrometry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602309

7 January 2021

Total antioxidant status in plasma and body fluids

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602309

7 January 2021

Red wine polyphenolic compounds inhibit atherosclerosis in apolipoprotein E-deficient mice independently of effects on lipid peroxidation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602309

7 January 2021

The association between diet and chronic obstructive pulmonary disease in subjects selected from general practice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602309

7 January 2021

Isoflavone phytoestrogens consumed in soy decrease F(2)-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602309

7 January 2021

Identifiers

DOI

10.1038/SJ.EJCN.1602309

1 reference

25 December 2017

PubMed ID

16278692

1 reference

25 December 2017